Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.

Saved in:
Bibliographic Details
Title: Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
Authors: Osunkwo I; Sickle Cell Disease Enterprise, The Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., James J; Sickle Cell Society, London, UK., El-Rassi F; Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, Georgia, USA., Nero A; University of Texas Southwestern Medical Center, Dallas, Texas, USA., Minniti CP; Albert Einstein College of Medicine, New York, New York, USA., Trimnell C; Sickle Cell 101, San Jose, California, USA., Paulose J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Ramscar N; Novartis Pharma AG, Basel, Switzerland., Bailey T; Adelphi Real World, Bollington, UK., Rajkovic-Hooley O; Adelphi Real World, Bollington, UK., Andemariam B; New England Sickle Cell Institute, University of Connecticut Health, Farmington, Connecticut, USA.
Source: American journal of hematology [Am J Hematol] 2022 Aug; Vol. 97 (8), pp. 1055-1064. Date of Electronic Publication: 2022 Jun 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-8652
DOI:10.1002/ajh.26576